Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioNet recombinant pertussis vaccine in pregnant women (phase II)
TCTR20210128004Phase 2Completed
- Sponsor
- Chulalongkorn University
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in pertussis, sponsored by Chulalongkorn University. Primary endpoints: Immunogenicity of BioNet recombinant pertussis vaccines and Safety of BioNet recombinant pertussis vaccines. Started Jun 2021; status: completed.
02
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20210128004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210128004.